| abstract |
formula Composition. Wherein R1, R2, and R3 are amino acid residues such as valine, sarcosine, leucine, glutamine, tryptophan, tyrosine, alanine, and 4 (4-aminophenyl) butyric acid or combinations thereof, and salts thereof. Methods for preparing these compositions and pharmaceutically acceptable formulations are used to treat any disease condition responsive to THC, including administration of at least one of these compositions in a pharmaceutically acceptable carrier. Method. [Selection] Figure 1 |